Report
Screening for vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic aciduria) in extended newborn screening (ENS)
Report documents
-
Extract of the final report
Screening for vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic aciduria) in extended newborn screening (ENS)
-
Final report
Screening for vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic aciduria) in extended newborn screening (ENS)
-
Documentation of comments on the preliminary report
Screening for vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic aciduria) in extended newborn screening (ENS)
-
Preliminary report
Screening for vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic aciduria) in extended newborn screening (ENS)
-
Report plan
Screening for vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic aciduria) in extended newborn screening (ENS)
Press releases
Newborn screening for vitamin B12 deficiency: benefits outweigh harms
Project details
- Project no.
- S22-02
- Commission
- Commission awarded on 25.11.2022 by the Federal Joint Committee (GBA).
- Report type
- Report
- Status
- Commission completed
- Department/Division
- Non-Drug Interventions
- Topic
- Children's and adolescents' health
- DOI
- https://doi.org/10.60584/S22-02_en